Trial intelligence / Profile preview

Remimazolam vs propofol for sedation in elderly patients undergoing upper gastrointestinal endoscopy

ChiCTR2100046476Phase 4Recruiting

Sponsor
First Affiliated Hospital, Zhejiang University School of Medicine
Start
Jun 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of remimazolam (2 arms), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoints: Successful sedation rate and Hypotension rate. Started Jun 2021; status: recruiting.

02

Drugs

remimazolam

Beyond the preview

Go deeper on ChiCTR2100046476.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100046476.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call